Vicore Pharma Holding AB (publ), a company developing innovative medicines for rare lung disorders, today announced that its CEO, Carl-Johan Dalsgaard, will present at the DNB Carnegie Nordic Healthcare Conference on November 9, 2022, at 14:00 CET. The presentation will provide an update on the company and its programs.
Wednesday, November 9, 2022
Vicore Pharma Holding AB (publ), a company developing innovative medicines for rare lung disorders, today announced that its CEO, Carl-Johan Dalsgaard, will present at the DNB Carnegie Nordic Healthcare Conference on November 9, 2022, at 14:00 CET. The presentation will provide an update on the company and its programs.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox